MATTHEW MILLER: Open Payments
NPI 1598386385 · SANTA BARBARA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,433 in 38 payments from 19 companies in 2025. Trend: 2023 $656 · 2024 $803 · 2025 $1,433
Food & beverage: $1,433
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $198 |
| Medtronic, Inc. | 2 | $171 |
| Boston Scientific Corporation | 3 | $146 |
| Gilead Sciences, Inc. | 1 | $129 |
| AstraZeneca Pharmaceuticals LP | 1 | $115 |
| Amgen Inc. | 1 | $91 |
| ABIOMED | 3 | $90 |
| PFIZER INC. | 4 | $85 |
| E.R. Squibb & Sons, L.L.C. | 4 | $83 |
| BridgeBio Pharma, Inc. | 2 | $60 |
Products named: JARDIANCE, AFFERA MAPPING SYSTEM, WATCHMAN Access System, Yeztugo, REPATHA, ELIQUIS, VYNDAQEL, Attruby.
Industry payments across CA — which companies pay providers there.
